Skip to content

Clarivate CLVT Debt issuance costs

Debt issuance costs at other companies

BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$4.95M
Tidewater logo
TidewaterTDW
$101K-98.0%
BrightView Holdings, Inc. logo
BrightView Holdings, Inc.BV
$1.3M
HWK
HawkinsHWKN
$764K
Celsius Holdings, Inc. logo
Celsius Holdings, Inc.CELH
$0-100%
Circle Internet Group, Inc. logo
Circle Internet Group, Inc.CRCL
$0-100%

Other financials

Income statement

See full
Revenue$585.5M-1.4%
Gross profit$393.4M+1.7%
Operating income$30.2M+245%
Net income-$40.2M+61.3%
EPS (diluted)-$0.06+60.0%

Balance sheet

See full
Cash & equivalents$242.2M-31.6%
Total debt$4.4B-5.7%
Total equity$4.8B-4.7%
Total assets$10.9B-4.9%

Cash flow

See full
Operating cash flow$134.7M-21.3%
CapEx$55.8M-8.4%
Free cash flow$78.9M-28.5%

Valuation

See full
Market cap$1.28B-55.2%
Enterprise value$5.45B-24.2%
P/S0.5×-0.6×

Profitability

See full
Gross margin66.5%+0.5pp
Operating margin5%+2.9pp
Net margin-5.7%-2.5pp
FCF margin13.6%-0.4pp

Returns & leverage

See full
Return on equity-2.9%-1.2pp
Debt / equity0.9×0.0×
Current ratio0.8×0.0×

Where this comes from

Reported directly by Clarivate in its filing.

Tagged under the XBRL concept clvt:DeferredTaxAssetsDebtIssuanceCosts.

The official record: Clarivate’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Clarivate's debt issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Clarivate's debt issuance costs?
Clarivate (CLVT) reported debt issuance costs of $7.9M in Q4 2025.
What does debt issuance costs mean?
This represents the capitalized costs incurred in the process of issuing debt, which are amortized over the life of the related debt instrument. It reflects the upfront financial burden of accessing capital markets. Monitoring these costs provides insight into the company's historical cost of borrowing and financing efficiency.